TP53 gene expression, codon 72 polymorphism and human papillomavirus DNA associated with pterygium

Genetics and Molecular Research

Volumn 7, Issue 4, 2008, Pages 1251-1258

  Rodrigues, F W ^a,b   Arruda, J T ^c   Silva, R E ^a,b   Moura, K K V O ^b,c  

^a Fundacao Banco de Olhos de Goias   (Brazil)

^b Programa de Pos Graduacao Stricto Sensu   (Brazil)

^c PONTIFÍCIA UNIVERSIDADE CATÓLICA DE GOIÁS   (Brazil)

Author keywords

Brazilian; Ophthalmology; Pterygia

Indexed keywords

ARGININE; PROLINE; PROTEIN P53; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; CODON; CONJUNCTIVA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; P53 GENE CODON 72; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PTERYGIUM; RISK FACTOR; VIRUS DETECTION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; AGED; ALLELES; ARGININE; CODON; DNA, VIRAL; FEMALE; GENE EXPRESSION; GENES, P53; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMORPHISM, GENETIC; PROLINE; PTERYGIUM; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 56749152342     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol7-4gmr528     Document Type: Article

References (39)

1. Beroud C and Soussi T (2003). The UMD-p53 database: new mutations and analysis tools. Hum. Mutat. 21: 176-181.
2. Chowers I, Pe'er J, Zamir E, Livni N, et al. (2001). Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology 108: 985-988.
3. Cullen AP (2002). Photokeratitis and other phototoxic effects on the cornea and conjunctiva. Int. J. Toxicol. 21: 455-464.
4. Detorakis ET, Drakonaki EE and Spandidos DA (2000). Molecular genetic alterations and viral presence in ophthalmic pterygium. Int. J. Mol. Med. 6: 35-41.
5. Detorakis ET, Sourvinos G and Spandidos DA (2001). Detection of herpes simplex virus and human papilloma virus in ophthalmic pterygium. Cornea 20: 164-167.
6. Di Girolamo N, McCluskey P, Lloyd A, Coroneo MT, et al. (2000). Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest. Ophthalmol. Vis. Sci. 41: 671-679.
7. Di Girolamo N, Kumar RK, Coroneo MT and Wakefield D (2002). UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest. Ophthalmol. Vis. Sci. 43: 3430-3437.
8. Dolmetsch AM, Alcocer CE, Scull JJ, Martins MC, et al. (1996). The presence of human papillomavirus in pterygia. Invest. Ophthalmol. Vis. Sci. 37: S43.
9. Dushku N and Reid TW (1997). P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr. Eye Res. 16: 1179-1192.
10. Dushku N, Hatcher SL, Albert DM and Reid TW (1999). p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch. Ophthalmol. 117: 1593-1599.
11. Gallagher MJ, Giannoudis A, Herrington CS and Hiscott P (2001). Human papillomavirus in pterygium. Is the virus a risk factor? Br. J. Ophthalmol. 85: 782-784.
12. Hirst LW (2003). The treatment of pterygium. Surv. Ophthalmol. 48: 145-180.
13. Husnjak K, Grce M, Magdic L and Pavelic K (2000). Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J. Virol. Methods 88: 125-134.
14. Hussein MR (2005). Ultraviolet radiation and skin cancer: molecular mechanisms. J. Cutan. Pathol. 32: 191-205.
15. Ichihashi M, Ueda M, Budiyanto A, Bito T, et al. (2003). UV-induced skin damage. Toxicology 189: 21-39.
16. Kau HC, Tsai CC, Lee CF, Kao SC, et al. (2006). Increased oxidative DNA damage, 8-hydroxydeoxy-guanosine, in human pterygium. Eye 20: 826-831.
17. Kria L, Ohira A and Amemiya T (1998). Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch. Clin. Exp. Ophthalmol. 236: 702-708.
18. Liu Z, Xie Y and Zhang M (2002). Overexpression of type I growth factor receptors in pterygium. Chin. Med. J. 115: 418-421.
19. Marcovich AL, Morad Y, Sandbank J, Huszar M, et al. (2002). Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr. Eye Res. 25: 17-22.
20. Nolan TM, DiGirolamo N, Sachdev NH, Hampartzoumian T, et al. (2003). The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium. Am. J. Pathol. 162: 567-574.
21. Onur C, Orhan D, Orhan M, Dizbay SS, et al. (1998). Expression of p53 protein in pterygium. Eur. J. Ophthalmol. 8: 157-161.
22. Perra MT, Maxia C, Zucca I, Piras F, et al. (2002). Immunohistochemical study of human pterygium. Histol. Histopathol. 17: 139-149.
23. Perra MT, Maxia C, Corbu A, Minerba L, et al. (2006). Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine. Mol. Vis. 12: 1136-1142.
24. Piras F, Moore PS, Ugalde J, Perra MT, et al. (2003). Detection of human papillomavirus DNA in pterygia from different geographical regions. Br. J. Ophthalmol. 87: 864-866.
25. Reisman D, McFadden JW and Lu G (2004). Loss of heterozygosity and p53 expression in pterygium. Cancer Lett. 206: 77-83.
26. Ribatti D, Nico B, Maxia C, Longo V, et al. (2007). Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J. Cell Mol. Med. 11: 585-589.
27. Sakoonwatanyoo P, Tan DT and Smith DR (2004). Expression of p63 in pterygium and normal conjunctiva. Cornea 23: 67-70.
28. Schneider BG, John-Aryankalayil M, Rowsey JJ, Dushku N, et al. (2006). Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation. Exp. Eye Res. 82: 91-98.
29. Storey A, Thomas M, Kalita A, Harwood C, et al. (1998). Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234.
30. Tan DT, Lim AS, Goh HS and Smith DR (1997). Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am. J. Ophthalmol. 123: 404-405.
31. Tan DT, Tang WY, Liu YP, Goh HS, et al. (2000). Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br. J. Ophthalmol. 84: 212-216.
32. Tsai YY, Tsai YY, Cheng YW, Lee H, et al. (2004). No association of p53 codon 72 and p21 codon 31 polymorphisms in Taiwan Chinese patients with pterygium. Br. J. Ophthalmol. 88: 975-976.
33. Tsai YY, Chang KC, Lin CL, Lee H, et al. (2005a). p53 Expression in pterygium by immunohistochemical analysis: a series report of 127 cases and review of the literature. Cornea 24: 583-586.
34. Tsai YY, Cheng YW, Lee H, Tsai FJ, et al. (2005b). P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Mol. Vis. 11: 50-55.
35. Tsai YY, Chang KC, Lee H, Cheng YW, et al. (2005c). Effect of p53 codon 72 polymorphism on p53 protein expression in pterygium. Clin. Exper. Ophthalmol. 33: 60-62.
36. Ueda Y, Kanazawa S, Kitaoka T, Dake Y, et al. (2001). Immunohistochemical study of p53, p21 and PCNA in pterygium. Acta Histochem. 103: 159-165.
37. van Setten G, Aspiotis M, Blalock TD, Grotendorst G, et al. (2003). Connective tissue growth factor in pterygium: simultaneous presence with vascular endothelial growth factor - possible contributing factor to conjunctival scarring. Graefes Arch. Clin. Exp. Ophthalmol. 241: 135-139.
38. Varinli S, Varinli I, Koksal EM and Doran F (1994). Human papillomavirus in pterygium. Cent. Afr. J. Med. 40: 24-26.
39. Weinstein O, Rosenthal G, Zirkin H, Monos T, et al. (2002). Overexpression of p53 tumor suppressor gene in pterygia. Eye 16: 619-621.